The Latest Breaking News from Mangeet Kaur BounsMangeet

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

Shares of communication services company Twilio (TWLO) have plunged more than 80% in price year-to-date due to deteriorating financials and broader market weakness. Renowned investor Cathie Wood has recently gone bargain-hunting and loaded up shares of TWLO. Since the stock is expected to decline further in the near term, it…

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

Telecom giant Verizon (VZ) is undertaking various measures, including cost-saving and increasing focus on executing its 5G strategy, to boost its growth. The company’s financial discipline and healthy balance sheet allow it to pay high-yield dividends. Hence, this stock could be an ideal investment in the current macro environment. Read…